BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 15, 2006
View Archived Issues
Third-generation anti-CD20 antibody shows promise for the treatment of B-cell lymphomas
Read More
Phase I/II data show activity of pralatrexate in peripheral T-cell lymphomas
Read More
Senicapoc safe, beneficial with long-term treatment in sickle cell disease
Read More
AKR-501 increases platelet counts in healthy subjects
Read More
Snapshots of recent clinical trials in glioma: Part II
Read More
In vitro efficacy of an anti-IGF-1R antibody, AVE-1642, in multiple myeloma
Read More
Helix studies topical interferon alpha-2b for anogenital warts
Read More
GSK and Epix establish GPCR collaboration
Read More
Indevus to acquire Valera
Read More
Bifeprunox NDA filed for review
Read More
Cell-mediated gene therapy studied for pulmonary arterial hypertension
Read More
Schwarz Pharma transfers urology R&D project to 4SC
Read More
Phase III study opens in U.S. for Grazax
Read More
Biofrontera advances phase IIb/III trial of BF-200 ALA in actinic keratosis
Read More
Anyara achieves proof of concept
Read More
Genmab announces fully human HuMax-ZP3 antibody program
Read More
European orphan drug designation for Sarcodoxome for soft tissue sarcoma
Read More
Lilly reviews pipeline progress
Read More
Novel treatment options for metabolic disorders described in recent patent literature
Read More
New agents for gastrointestinal disorders reported in recent patents
Read More
Merck & Co. reviews pipeline status
Read More
Biomira reaches SPA for phase III Stimuvax trial
Read More
Sanctura XR NDA accepted for review
Read More
Tykerb studied as adjuvant treatment in early-stage HER2-positive breast cancer
Read More
KRX-0401 begins phase II for rare sarcomas
Read More
MicroIslet holds pre-IND meeting for allotransplantation approach in diabetes
Read More
Phase II data support once-daily Gabapentin GR in diabetic peripheral neuropathy
Read More
Interim safety analysis findings from phase IIb telaprevir HCV study
Read More
PI-88 increases disease-free survival by 76% in hepatocellular cancer study
Read More
Antagonists of adrenomedullin may be useful to treat bone metastasis
Read More